comparemela.com

Latest Breaking News On - Pashtoon murtaza kasi - Page 1 : comparemela.com

Dr Kasi on the Potential Implications of ctDNA presence in Colorectal Cancer

Dr Kasi on the Potential Implications of ctDNA presence in Colorectal Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Pashtoon murtaza kasiWeill cornell medicineNewyork presbyterian hospital

Dr Kasi on the Use of ctDNA to Help Inform Adjuvant Treatment Decisions in CRC

Pashtoon Murtaza Kasi, MD, M.S on the potential of ctDNA to guide further adjuvant treatment decisions in CRC and other tumor types.

Pashtoon murtaza kasiWeill cornell medicineNewyork presbyterian hospital

Uncertainty Surrounds Sensitivity of ctDNA in CRC

ctDNA is a useful prognostic tool in CRC, but it's unclear whether it can guide the use of adjuvant chemotherapy.

United statesMemorial sloan kettering cancer centerNew yorkDavid ellisonAparna raj parikhHiroki yukamiEujung kimHarvard medical schoolPeter maccallum cancer centrePashtoon murtaza kasiWeill cornell medicineJeannie tieRaj parikhNot sensitiveColorectal cancerColorectal cancer crc

Neoadjuvant Botensilimab/Balstilimab Produces Early Responses in CRC

Patients with resectable mismatch repair-proficient and -deficient colorectal cancer had robust responses to neoadjuvant botensilimab/balstilimab.

Newyork presbyterian hospitalNew yorkUnited statesPashtoon murtaza kasiWeill cornell medicineGastric cancerColorectal cancerAsco gi

Cancer in Bloodstream May Predict CRC Outcomes

Circulating tumor DNA-based minimal residual disease lent insight into which patients with stage 2/3 colorectal cancer may be at higher risk for recurrence and which could benefit from postsurgical chemotherapy.

United statesNew yorkPashtoon murtaza kasiWeill cornell medicineNew york presbyterian hospitalGastric cancerColorectal cancerAsco gi

vimarsana © 2020. All Rights Reserved.